SIM
DFTX

Sonora Investment Management’s Definium Therapeutics DFTX Stock Holding History

Sonora Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$8K Hold
233
– – ﹤0.01% 815
2021
Q2 		$12K Buy
+233
New +$12.2K ﹤0.01% 681

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $4.12B AUM 32.66% 1-Year Est. Return

Sonora Investment Management's DFTX Position: Q3 2021 in Review

Sonora Investment Management held its Definium Therapeutics (DFTX) position steady in Q3 2021 at 233 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Sonora Investment Management first reported a position in DFTX in Q2 2021 and has held it in 2 quarters since. The position peaked at $12K in Q2 2021. 174 funds tracked by Wall St. Rank hold DFTX as of Q3 2021.

  • Sonora Investment Management held 233 shares of Definium Therapeutics worth $8K as of Q3 2021.
  • Sonora Investment Management left its Definium Therapeutics share count unchanged in Q3 2021.
  • Definium Therapeutics made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #815 holding.
  • Sonora Investment Management first reported a position in Definium Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • Sonora Investment Management's Definium Therapeutics position peaked at $12K in Q2 2021.
  • 174 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.